Voloridge Investment Management
ISEE

Voloridge Investment Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Voloridge Investment Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-407,692
Closed -$6.82M – 1794
2021
Q4 		$6.82M Sell
407,692
-469,990
-54% -$7.7M 0.04% 597
2021
Q3 		$14.3M Buy
+877,682
New +$9.55M 0.09% 302
2017
Q1 		– Sell
-56,543
Closed -$273K – 737
2016
Q4 		$273K Buy
+56,543
New +$1.68M 0.01% 597

Other funds holding ISEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Voloridge Investment Management's ISEE Position: Q1 2022 in Review

Voloridge Investment Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2022, closing a stake of 407,692 shares — an estimated $6.82M sold.

Voloridge Investment Management first reported a position in ISEE in Q4 2016 and held it in 3 quarters. The position peaked at $14.3M in Q3 2021. 163 funds tracked by Wall St. Rank hold ISEE as of Q1 2022.

  • Voloridge Investment Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 407,692 IVERIC bio, Inc. Common Stock shares in Q1 2022, an estimated $6.82M.
  • Voloridge Investment Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 3 quarters.
  • Voloridge Investment Management's IVERIC bio, Inc. Common Stock position peaked at $14.3M in Q3 2021.
  • 163 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.